Efficacy and Safety of Polyene Phosphatidylcholine in Treatment of Patients With Acute Drug-induced Liver Injury
Status:
Completed
Trial end date:
2020-11-02
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the efficacy and the safety of polyene
phosphatidylcholine Injection in patients with acute drug-induced liver injury after 2-4
weeks of treatment.
Phase:
Phase 4
Details
Lead Sponsor:
Sichuan Haisco Pharmaceutical Group Co., Ltd Sichuan Haisco Pharmaceutical Group Co., Ltd.